Cargando…
Serotonin-releasing agents with reduced off-target effects
Increasing extracellular levels of serotonin (5-HT) in the brain ameliorates symptoms of depression and anxiety-related disorders, e.g., social phobias and post-traumatic stress disorder. Recent evidence from preclinical and clinical studies established the therapeutic potential of drugs inducing th...
Autores principales: | Mayer, Felix P., Niello, Marco, Cintulova, Daniela, Sideromenos, Spyridon, Maier, Julian, Li, Yang, Bulling, Simon, Kudlacek, Oliver, Schicker, Klaus, Iwamoto, Hideki, Deng, Fei, Wan, Jinxia, Holy, Marion, Katamish, Rania, Sandtner, Walter, Li, Yulong, Pollak, Daniela D., Blakely, Randy D., Mihovilovic, Marko D., Baumann, Michael H., Sitte, Harald H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645344/ https://www.ncbi.nlm.nih.gov/pubmed/36352123 http://dx.doi.org/10.1038/s41380-022-01843-w |
Ejemplares similares
-
Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro
por: Niello, Marco, et al.
Publicado: (2021) -
Unifying Concept of Serotonin Transporter-associated Currents
por: Schicker, Klaus, et al.
Publicado: (2012) -
Persistent binding at dopamine transporters determines sustained psychostimulant effects
por: Niello, Marco, et al.
Publicado: (2023) -
The presence of phosphatidylinositol-4,5-bisphosphate directly impacts on amphetamine-induced serotonin transporter-mediated efflux
por: Buchmayer, Florian, et al.
Publicado: (2008) -
The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine Transporters
por: Bulling, Simon, et al.
Publicado: (2012)